Shandong Longli Biological Technology Co., Ltd. (hereinafter referred to as "the Company") approved the proposal to authorize the board of directors to sign relevant agreements after the suspension of the company's stock listing at the fourth meeting of the fourth board of directors and the 2018 annual general meeting held on April 29, 2019, and June 27, 2019, respectively. Details can be found in the "Resolution Announcement of the Fourth Meeting of the Fourth Board of Directors" (Announcement No. 2019-028) published on April 30, 2019, and the "Resolution Announcement of the 2018 Annual General Meeting" (Announcement No. 2019-052) published on
002604SZSE
Announcement on Change of Custodian Institution
✨ AI Summary
Shandong Longli Biological Technology Co., Ltd. has decided to terminate its strategic cooperation framework agreement with Huaxi Securities Co., Ltd. Following this, the company signed new agreements with Jiuzhou Securities Co., Ltd. to facilitate its listing restoration and stock transfer services. The board ensures accurate and complete information disclosure.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.